Merck Urges Justices To Save Historic $2.5B Patent Verdict
By Dani Kass ( September 25, 2020, 7:18 PM EDT) -- A Merck & Co. unit has asked the U.S. Supreme Court to answer key questions related to whether a hepatitis C treatment patent is invalid in hopes of reviving a $2.54 billion infringement verdict against Gilead — the largest in the nation's history....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.